Resources from the same session
376MO - The impact of crossover to surgery in the no-surgery group on the survival: A post-hoc analysis of the SOC-1 trial
Presenter: Lina Shen
Session: Mini Oral session: Gynaecological cancers
Resources:
Abstract
Slides
Webcast
377MO - Lymph node dissection before initial treatment for locally advanced cervical cancer: A systematic review and meta-analysis
Presenter: He Zhang
Session: Mini Oral session: Gynaecological cancers
Resources:
Abstract
Slides
Webcast
Q&A and discussion
Session: Mini Oral session: Gynaecological cancers
Resources:
Webcast
378MO - Efficacy and safety of disitamab vedotin in treatment of HER2 expressed advanced or recurrent gynecological cancers
Presenter: Dongyan Wang
Session: Mini Oral session: Gynaecological cancers
Resources:
Abstract
Slides
Webcast
379MO - Homologous recombination deficiency testing in Vietnamese patients with ovarian cancer
Presenter: Nam Tran
Session: Mini Oral session: Gynaecological cancers
Resources:
Abstract
Invited Discussant 378MO and 379MO
Presenter: Clare Scott
Session: Mini Oral session: Gynaecological cancers
Resources:
Slides
Webcast
380MO - Role of therapy in the development of second primary malignancies in ovarian cancer survivors: A SEER database analysis
Presenter: Alhareth Alhusban
Session: Mini Oral session: Gynaecological cancers
Resources:
Abstract
Slides
Webcast
381MO - Progression free survival and overall survival in platinum-based chemotherapy alone versus immune checkpoint inhibitor (ICI)-platinum-based chemotherapy combination in first-line treatment for advanced, metastatic or recurrent endometrial adenocarcinoma: A meta-analysis
Presenter: Maria Carmela Vistal
Session: Mini Oral session: Gynaecological cancers
Resources:
Abstract
Slides
Webcast
Q&A and discussion
Session: Mini Oral session: Gynaecological cancers
Resources:
Webcast